Multiple Sclerosis (MS) Market Research Reports & Industry Analysis
The prevalence rate of MS in the United States is approximately 57.8 per 100,000. Above the 37th parallel, the prevalence is reported at 68.8 per 100,000, and below it, it is reported at 35.5 per 100,000 Scientists continue their extensive efforts to create new and better therapies for MS. One of the most promising MS research areas involves naturally occurring antiviral proteins known as interferons. Beta interferon has been shown to reduce the number of exacerbations and may slow the progression of physical disability.
When attacks do occur, they tend to be shorter and less severe. In addition, there are a number of treatments under investigation that may curtail attacks or improve function. Over a dozen clinical trials testing potential therapies are underway, and additional new treatments are being devised and tested in animal models. There are a variety of treatments for M.S. which are indicated to slow the progress of the disease.
Multiple Sclerosis (MS) Industry Research & Market Reports
-
Global Non-Oncology Biopharmaceuticals Market - 2025-2033
... 2025-2033. The global non-oncology biopharmaceuticals market is growing due to the rising demand for advanced biologic therapies for chronic and non-cancerous conditions. Technological advancements in biologics, such as monoclonal antibodies, recombinant proteins, and gene therapies, ... Read More
-
Biomarkers Market by Offering (Consumables, Software, Services), Type (Safety, Efficacy), Research Area (Genomics, Proteomics), Technology (PCR, MS), Disease (Cancer, Infectious, Neurological), Application (Diagnostic, Research) - Global Forecast to 2030
... to the advantage that these assay kits offer standardized and optimized protocols, facilitating accurate and efficient analysis of biomarkers in various biological samples, thus contributing significantly to diagnostic and research endeavors in healthcare. Further, advances ... Read More
-
Neurological Biomarkers Market, By Biomarker Type (Artificial Tears, Imaging Biomarkers, Metabolomics Biomarkers, Proteomic Biomarkers, Genomics Biomarkers), By Application (Alzheimers Disease, Parkinsons Disease, Multiple Sclerosis, Autism Spectrum Disorders, Others), By End User (Hospital Laboratories, Clinical Diagnostic Centers, Research Organizations, Others), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)
... such as Alzheimer's disease, Parkinson's disease, multiple sclerosis and others can boost demand for reliable neurological biomarkers. Furthermore, growing focus on development of precision medicine and companion diagnostics for neurological conditions can drive the market ... Read More
-
2025 Global Forecast for Multiple Sclerosis Therapeutics Market (2026-2031 Outlook)-High Tech Outlook Report
... or service category is within the NAICS Medical Laboratories industry. The product or service category is within the NAICS Medical Laboratories industry. The global market is expected to increase from USD xx billion in 2026 ... Read More
-
Autoinjector Market Report by Type (Disposable Autoinjectors, Reusable Autoinjectors), Application (Rheumatoid Arthritis, Anaphylaxis, Multiple Sclerosis, and Others), End User (Home Care Settings, Hospitals and Clinics), and Region 2025-2033
... increasing prevalence of chronic diseases, continuous advancements in biologics and biosimilars, the rising preference for home healthcare, numerous product innovations, and supportive reimbursement policies, are some of the factors driving the market. Autoinjectors are self-injectable ... Read More
-
Multiple Sclerosis Drugs Global Market Report 2025
... market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond. Reasons to Purchase Gain a truly global perspective ... Read More
-
Neurological Biomarkers Market Size, Share & Trends Analysis Report By Application (Alzheimer’s, Parkinson’s, Multiple Sclerosis, Autism), By Type, By End Use, By Region, And Segment Forecasts, 2025 - 2030
... report by Grand View Research, Inc. Increased funding for R&D of neurological biomarkers to boost development of new drugs is expected to impel market growth. National Institute of Neurological Disorders and Stroke provides funding opportunities ... Read More
-
Beta Interferon
... CAGR of 3.0% over the analysis period 2024-2030. The U.S. Market is Estimated at US$968.9 Million While China is Forecast to Grow at 4.5% CAGR The Beta Interferon market in the U.S. is estimated at ... Read More
-
Multiple Sclerosis Drugs
... at a CAGR of 6.7% over the analysis period 2024-2030. Immmunomoderator Drugs, one of the segments analyzed in the report, is expected to record a 7.4% CAGR and reach US$13.2 Billion by the end of ... Read More
-
Neuroregeneration Therapy Market, By Type of Neuroregeneration Therapy (Stem Cell Therapy, Gene Therapy, Pharmacological Therapy, Neurostimulation Therapy, Others), By Indication (Spinal Cord Injury, Stroke, Traumatic Brain Injury, Parkinson\\\'s Disease, Alzheimer\\\'s Disease, Multiple Sclerosis, Peripheral Nerve Injury, Others), By Mode of Administration (Oral, Injectable, Implantable, Others), By Age Group (Pediatric, Adult, Geriatric), By End User (Hospitals, Specialty Clinics, Research Institutes, Rehabilitation Centers, Others), By Geography (North America, Latin America, Europe, Middle East & Africa, and Asia Pacific)
... involves the synthesis of new neurons and connections, providing additional resources to substitute the damaged ones. Neuroregeneration is not just about physical recovery; it's also a vital mechanism for maintaining cognitive functions. It plays a ... Read More
-
Medical Marijuana Market Size, Share, and Outlook, 2025 Report- By Product (Flower, Oil & Tinctures ), By Application (Cancer, Chronic Pain, Depression and Anxiety, Arthritis, Diabetes, Glaucoma, Migraines, Epilepsy, Multiple Sclerosis, AIDS, Amyotrophic Lateral Sclerosis, Alzheimer’s Disease, Post-Traumatic Stress Disorder (PTSD), Parkinson's Disease, Tourettes, Others), 2021-2032
... growing and presents potential growth opportunities for companies across the industry value chain. The comprehensive market research report presents 12-year historic and forecast data on Medical Marijuana segments across 22 countries from 2021 to 2032. ... Read More
-
Multiple Sclerosis Therapeutics Market Size, Share, and Outlook, 2025 Report- By Drug (Large-molecule Drugs, Small-molecule Drugs), By Route of Administration (Oral, Injectable, Others), 2021-2032
... poised to keep growing and presents potential growth opportunities for companies across the industry value chain. The comprehensive market research report presents 12-year historic and forecast data on Multiple Sclerosis Therapeutics segments across 22 countries ... Read More
-
Neurorehabilitation Devices Market Size, Share, and Outlook, 2025 Report- By Product (Neurorobotics, Brain-Computer Interface, Wearable Devices, Non-Invasive Stimulators, Others), By Therapy Area (Stroke, Parkinson’s Disease, Multiple Sclerosis, Cerebral Palsy, Others), 2021-2032
... growing and presents potential growth opportunities for companies across the industry value chain. The comprehensive market research report presents 12-year historic and forecast data on Neurorehabilitation Devices segments across 22 countries from 2021 to 2032. ... Read More
-
Immunoassay for Neurological Biomarkers Market Size, Share, and Outlook, 2025 Report- By Product (Instruments, Reagents, Services), By Disease (Alzheimer's Disease, Parkinson's Disease, Multiple Sclerosis, Others), By Application (In Vitro Diagnostics Application, Research Application), 2021-2032
... business that is poised to keep growing and presents potential growth opportunities for companies across the industry value chain. The comprehensive market research report presents 12-year historic and forecast data on Immunoassay for Neurological Biomarkers ... Read More
-
Neurological Biomarkers Market Size, Share, and Outlook, 2025 Report- By Type (Genomic, Proteomic, Metabolomic, Imaging, Others), By Application (Alzheimer's Disease, Parkinson's Disease, Multiple Sclerosis, Autism Spectrum Disorder, Others), By End-user (Hospital & Hospital Laboratories, Independent clinical diagnostic centers, Research Organizations, Others), 2021-2032
... growing and presents potential growth opportunities for companies across the industry value chain. The comprehensive market research report presents 12-year historic and forecast data on Neurological Biomarkers segments across 22 countries from 2021 to 2032. ... Read More
-
Active Wheelchair Market Size, Share, and Outlook, 2025 Report- By Product (Manual Wheelchairs, Power Wheelchairs), By Indication (Alzheimer’s Disease, Amyotrophic Lateral Sclerosis (ALS), Multiple Sclerosis, Diabetes, Cerebral Palsy, Muscular Dystrophy, Parkinson’s Disease, Scoliosis, Spina Bifida, Spinal Cord Injury, Others), 2021-2032
... growing and presents potential growth opportunities for companies across the industry value chain. The comprehensive market research report presents 12-year historic and forecast data on Active Wheelchair segments across 22 countries from 2021 to 2032. ... Read More
-
Continence Care Market Size, Share, and Outlook, 2025 Report- By Product (Urinary Catheters, Catheter Maintenance/Care, Urinary Bags), By Application (Diabetes, Strokes, BPH, Alzheimer, Cerebral Palsy, Parkinson, Prostate cancer, Spinal Cord Injury, Bladder Cancer, Multiple sclerosis, Spina Bifida, Others), By Bag Usage, Sterile bags, Non-sterile bags), By End-User (Home Care Settings, Hospitals, Others), 2021-2032
... growing and presents potential growth opportunities for companies across the industry value chain. The comprehensive market research report presents 12-year historic and forecast data on Continence Care segments across 22 countries from 2021 to 2032. ... Read More
-
Autoinjectors Market by Usage (Disposable, Reusable), Technology (Manual, Automatic), Therapy (Rheumatoid Arthritis, Diabetes, Obesity, Anaphypaxis, Multiple Sclerosis), Route of Administration (SC, IM), Volume (<3ml, >3ml) - Global Forecast to 2030
... is projected to surge to a value of USD 134.27 billion in 2030 from USD 67.30 billion in 2024, growing at a CAGR of 12.2%. Favorable reimbursement policies in North America and Europe coupled with ... Read More
-
Neurological Disorder Diagnostics Market Size, Share, By Product (Imaging Systems and In-vitro Diagnostics), Disease Indication (Strokes, Multiple Sclerosis, Neurodegenerative Diseases, Headaches, Sleep Disorder, and Others), End-User (Hospitals, Specialty Clinics, Diagnostic Centers, and Ambulatory Care Centers) and Region - Trends, Analysis, and Forecast till 2035
... and Region - Trends, Analysis, and Forecast till 2035 Neurological disorder diagnostics is the process of evaluating and identifying neurological disorder by performing neurological examination, patient’s medical history, and diagnostic tests, such as MRI and ... Read More
-
South & Central America Intermittent Catheters Market Forecast to 2031 - Regional Analysis - by Product (Coated Intermittent Catheters and Uncoated Intermittent Catheters), Indication [Urinary Incontinence, General Surgeries, Spinal Cord Injuries, Parkinson's Disease (PD), Multiple Sclerosis, and Others], Category (Female Length Catheters, Male Length Catheters, and Kid Length Catheters), System Type (Closed Intermittent Catheters Systems and Open Intermittent Catheters Systems), and End User (Hospitals, Ambulatory Surgical Centers, Home Care Settings, and Others)
... from 2023 to 2031. Growing Preference for Self-Catheterization and Increasing Investments in Urinary Catheter Developments Fuels South & Central America Intermittent Catheters Market Benign prostatic hyperplasia (BPH) and prostatitis are among the most common reasons ... Read More
-
South & Central America Medical Exoskeleton Market Forecast to 2031 - Regional Analysis - by Component (Hardware and Software), Type (Powered Exoskeleton and Passive Exoskeleton), Extremity (Lower Body Exoskeleton, Upper Body Exoskeleton, and Full Body Exoskeleton), Application (Spinal Cord Injury, Multiple Sclerosis, Stroke, Cerebral Palsy, Parkinson's Disease, and Others), Mobility (Mobile Exoskeleton and Stationary Exoskeleton), and End Users (Rehabilitation Centers, Physiotherapy Centers, Long Term Care Centers, Homecare Settings, and Others)
... from 2023 to 2031. Increasing Prevalence of SCI Fuels South & Central America Medical Exoskeleton Market Reduced physical activity and the predominance of seated activities can lead to severe physical and psychological deterioration in people ... Read More
-
North America Intermittent Catheters Market Forecast to 2031 - Regional Analysis - by Product (Coated Intermittent Catheters and Uncoated Intermittent Catheters), Indication [Urinary Incontinence, General Surgeries, Spinal Cord Injuries, Parkinson's Disease (PD), Multiple Sclerosis, and Others], Category (Female Length Catheters, Male Length Catheters, and Kid Length Catheters), System Type (Closed Intermittent Catheters Systems and Open Intermittent Catheters Systems), and End User (Hospitals, Ambulatory Surgical Centers, Home Care Settings, and Others)
... to 2031. Surging Prevalence of Urinary Incontinence Fuels North America Intermittent Catheters Market Urinary incontinence (UI) is the most common problem affecting a substantial global population. It results in occasional or minor leaking or uncontrolled ... Read More
-
Asia Pacific Medical Exoskeleton Market Forecast to 2031 - Regional Analysis - by Component (Hardware and Software), Type (Powered Exoskeleton and Passive Exoskeleton), Extremity (Lower Body Exoskeleton, Upper Body Exoskeleton, and Full Body Exoskeleton), Application (Spinal Cord Injury, Multiple Sclerosis, Stroke, Cerebral Palsy, Parkinson's Disease, and Others), Mobility (Mobile Exoskeleton and Stationary Exoskeleton), and End Users (Rehabilitation Centers, Physiotherapy Centers, Long Term Care Centers, Homecare Settings, and Others)
... to 2031. Increasing Prevalence of SCI Boosts Asia Pacific Medical Exoskeleton Market Reduced physical activity and the predominance of seated activities can lead to severe physical and psychological deterioration in people suffering from SCI. Secondary ... Read More
-
Middle East & Africa Medical Exoskeleton Market Forecast to 2031 - Regional Analysis - by Component (Hardware and Software), Type (Powered Exoskeleton and Passive Exoskeleton), Extremity (Lower Body Exoskeleton, Upper Body Exoskeleton, and Full Body Exoskeleton), Application (Spinal Cord Injury, Multiple Sclerosis, Stroke, Cerebral Palsy, Parkinson's Disease, and Others), Mobility (Mobile Exoskeleton and Stationary Exoskeleton), and End Users (Rehabilitation Centers, Physiotherapy Centers, Long Term Care Centers, Homecare Settings, and Others)
... from 2023 to 2031. Increasing Technological Advancements and Rising Investments Bolster Middle East & Africa Medical Exoskeleton Market Globally, people strive for better health and do not compromise with low-quality products. Owing to this, continuous ... Read More
-
Europe Medical Exoskeleton Market Forecast to 2031 - Regional Analysis - by Component (Hardware and Software), Type (Powered Exoskeleton and Passive Exoskeleton), Extremity (Lower Body Exoskeleton, Upper Body Exoskeleton, and Full Body Exoskeleton), Application (Spinal Cord Injury, Multiple Sclerosis, Stroke, Cerebral Palsy, Parkinson's Disease, and Others), Mobility (Mobile Exoskeleton and Stationary Exoskeleton), and End Users (Rehabilitation Centers, Physiotherapy Centers, Long Term Care Centers, Homecare Settings, and Others)
... 2031. Growing Incidence of Stroke and Musculoskeletal Drives Europe Medical Exoskeleton Market Despite the advancements in the medical industry, stroke continues to be a major public health issue. Stroke ranks second in the world in ... Read More
Research Assistance
